CBU
RPRX icon

CIBC Bancorp USA’s Royalty Pharma RPRX Stock Holding History

CIBC Bancorp USA’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
18,566
+779
+4% +$40.5K ﹤0.01% 1096
2026
Q1 		$853K Buy
+17,787
New +$779K ﹤0.01% 1076
2025
Q3 		$480K Buy
+13,598
New +$492K ﹤0.01% 889

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIBC Bancorp USA's RPRX Position: Q2 2026 in Review

CIBC Bancorp USA increased its Royalty Pharma (RPRX) stake by 4.4% in Q2 2026, buying an estimated $40.5K and bringing the position to 18,566 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1096.

CIBC Bancorp USA first reported a position in RPRX in Q3 2025 and has held it in 3 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • CIBC Bancorp USA held 18,566 shares of Royalty Pharma worth $1.04M as of Q2 2026.
  • CIBC Bancorp USA bought 779 Royalty Pharma shares in Q2 2026, an estimated $40.5K.
  • Royalty Pharma made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1096 holding.
  • CIBC Bancorp USA first reported a position in Royalty Pharma in Q3 2025 and has held it in 3 quarters since.
  • 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.